Instylla HES Hypervascular Tumor Pivotal Study
Public ClinicalTrials.gov record NCT04523350. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Multi-Center, Subject and Evaluator Blinded, Parallel-Group Study to Evaluate the Safety and Effectiveness of the Instylla Hydrogel Embolic System (HES) Compared With Standard of Care Transcatheter Arterial Embolization (TAE) / Transcatheter Arterial Chemoembolization (cTACE) for Vascular Occlusion of Hypervascular Tumors; A Pivotal Study
Study identification
- NCT ID
- NCT04523350
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Instylla, Inc.
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- Instylla HES Device
- TAE or cTACE Other
Device · Other
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2021
- Primary completion
- Apr 30, 2024
- Completion
- Nov 18, 2024
- Last update posted
- Dec 15, 2024
2021 – 2024
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Hospital | Birmingham | Alabama | 35233 | — |
| Central Arkansas Radiation Therapy Institute, Inc. | Little Rock | Arkansas | 72205 | — |
| University of California, Irvine | Irvine | California | 92697- 7600 | — |
| Memorial Health Services | Long Beach | California | 92708 | — |
| Olive View-UCLA Education & Research Institute | Sylmar | California | 91342-1495 | — |
| St. Elizabeth Healthcare | Edgewood | Kentucky | 41017 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| Summit Health | Florham Park | New Jersey | 07932 | — |
| New York and Presbyterian Hospital (Cornell/Weill Medical College) | New York | New York | 10065 | — |
| Charlotte Radiology | Charlotte | North Carolina | 28202 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104-6061 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04523350, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 15, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04523350 live on ClinicalTrials.gov.